{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["carcinoma", "chemoembolization", "hepatocellular", "lidocaine hydrochloride", "pain management", "therapeutic"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34676180", "DateRevised": {"Year": "2022", "Month": "04", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "10", "Day": "05"}], "Language": ["eng"], "ELocationID": ["10.2147/JHC.S331779"], "Journal": {"ISSN": "2253-5969", "JournalIssue": {"Volume": "8", "PubDate": {"Year": "2021"}}, "Title": "Journal of hepatocellular carcinoma", "ISOAbbreviation": "J Hepatocell Carcinoma"}, "ArticleTitle": "Intraarterial Lidocaine Administration for Pain Control by Water-in-Oil Technique in Transarterial Chemoembolization: in vivo and Randomized Clinical Trial.", "Pagination": {"StartPage": "1221", "EndPage": "1232", "MedlinePgn": "1221-1232"}, "Abstract": {"AbstractText": ["To investigate the sustained release of lidocaine from a lidocaine-epirubicin-lipiodol emulsion created by water-in-oil (W/O) technique in vivo and evaluate the efficacy and safety of intraarterial lidocaine administration for intra- and postoperative pain control in transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).", "The in vivo concentrations of lidocaine were determined in tumor tissues after VX2 rabbit models for hepatic tumor were administered with intra-arterial lidocaine-epirubicin-lipiodol emulsion. A prospective randomized controlled clinical trial was performed, enrolling 70 consecutive patients who underwent TACE. Patients were randomized into two groups: Group A received an immediate bolus intraarterial lidocaine injection before TACE, and Group B received a lidocaine-epirubicin-lipiodol emulsion during TACE. Pain intensity was compared between the two groups using a visual analog scale (VAS) score before (T<sub>before</sub>) and at 0 h (T<sub>0</sub>), 4 h (T<sub>4</sub>), 8 h (T<sub>8</sub>), 24 h (T<sub>24</sub>), 48 h (T<sub>48</sub>), and 72 h (T<sub>72</sub>) after the procedure. Adverse events and intake of analgesics were evaluated and compared between the two groups.", "The concentrations of lidocaine in tumor tissues were higher in experimental group than in control group at T<sub>0.5</sub> (P=0.004), T<sub>1</sub> (P=0.038), T<sub>4</sub> (P=0.036), and T<sub>8</sub> (P=0.029). In the clinical trial, VAS scores in Group B were significantly lower than in Group A at T<sub>0</sub> (P=0.006), T<sub>4</sub> (P=0.001), T<sub>8</sub> (P=0.002), and T<sub>24</sub> (P=0.005). The tramadol intake in Group B was significantly lower than in Group A (P=0.021). No significant difference was observed regarding the incidence of adverse events between the two groups.", "This study demonstrated the effectiveness and safety of intraarterial lidocaine administration using the W/O technique in controlling intra- and post-TACE pain."], "CopyrightInformation": "\u00a9 2021 Wang et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Interventional Radiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Wang", "ForeName": "Li-Zhou", "Initials": "LZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The State Laboratory of Functions and Application of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Hu", "ForeName": "Xiao-Xia", "Initials": "XX"}, {"Identifier": ["0000-0002-4333-9106"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The State Laboratory of Functions and Application of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Shen", "ForeName": "Xiang-Chun", "Initials": "XC"}, {"Identifier": ["0000-0002-5908-2771"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China."}], "LastName": "Wang", "ForeName": "Tian-Cheng", "Initials": "TC"}, {"Identifier": ["0000-0001-6410-3306"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Interventional Radiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, People's Republic of China."}], "LastName": "Zhou", "ForeName": "Shi", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "J Hepatocell Carcinoma", "NlmUniqueID": "101674775", "ISSNLinking": "2253-5969"}, "CoiStatement": "The authors declare that there is no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mokrane FZ, Lu L, Vavasseur A, et al. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules. Eur Radiol. 2020;30(1):558\u2013570. doi:10.1007/s00330-019-06347-w", "ArticleIdList": ["10.1007/s00330-019-06347-w", "31444598"]}, {"Citation": "Zhang Z, Zhou Y, Yang J, et al. The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis. BMC Cancer. 2019;19(1):511. doi:10.1186/s12885-019-5735-9", "ArticleIdList": ["10.1186/s12885-019-5735-9", "PMC6542001", "31142283"]}, {"Citation": "Kim W, Cho SK, Shin SW, et al. Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy. Abdom Radiol. 2019;44(6):2283\u20132292. doi:10.1007/s00261-019-01952-1", "ArticleIdList": ["10.1007/s00261-019-01952-1", "30806742"]}, {"Citation": "Eilard MS, Andersson M, Naredi P, et al. A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation. BMC Cancer. 2019;19(1):568. doi:10.1186/s12885-019-5760-8", "ArticleIdList": ["10.1186/s12885-019-5760-8", "PMC6560824", "31185950"]}, {"Citation": "Peng Z, Chen S, Xiao H, et al. Microvascular invasion as a predictor of response to treatment with sorafenib and transarterial chemoembolization for recurrent intermediate-stage hepatocellular carcinoma. Radiology. 2019;292(1):237\u2013247. doi:10.1148/radiol.2019181818", "ArticleIdList": ["10.1148/radiol.2019181818", "31135299"]}, {"Citation": "Amorim J, Franca M, Perez-Girbes A, et al. Critical review of HCC imaging in the multidisciplinary setting: treatment allocation and evaluation of response. Abdom Radiol. 2020;45(10):3119\u20133128. doi:10.1007/s00261-020-02470-1", "ArticleIdList": ["10.1007/s00261-020-02470-1", "32173774"]}, {"Citation": "Kudo M, Han K, Ye S, et al. A changing paradigm for the treatment of intermediate-stage hepatocellular carcinoma: Asia-Pacific primary liver cancer expert consensus statements. Liver Cancer. 2020;9(3):245\u2013260. doi:10.1159/000507370", "ArticleIdList": ["10.1159/000507370", "PMC7325125", "32647629"]}, {"Citation": "Lee DH, Lee JM, Kim PN, et al. Whole tumor ablation of locally recurred hepatocellular carcinoma including retained iodized oil after transarterial chemoembolization improves progression-free survival. Eur Radiol. 2019;29(9):5052\u20135062. doi:10.1007/s00330-018-5993-y", "ArticleIdList": ["10.1007/s00330-018-5993-y", "30770968"]}, {"Citation": "Piscaglia F, Ogasawara S. Patient selection for transarterial chemoembolization in hepatocellular carcinoma: importance of benefit/risk assessment. Liver Cancer. 2018;7(1):104\u2013119. doi:10.1159/000485471", "ArticleIdList": ["10.1159/000485471", "PMC5892363", "29662837"]}, {"Citation": "Ogasawara S, Chiba T, Ooka Y, et al. A randomized placebo-controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization. Hepatology. 2018;67(2):575\u2013585. doi:10.1002/hep.29403", "ArticleIdList": ["10.1002/hep.29403", "28746788"]}, {"Citation": "Guo J, Zhao L, Rao Y, et al. Novel multimodal analgesia regimen improves post-TACE pain in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2018;17(6):510\u2013516. doi:10.1016/j.hbpd.2018.08.001", "ArticleIdList": ["10.1016/j.hbpd.2018.08.001", "30135046"]}, {"Citation": "Andersen KJ, Gr\u00f8nbaek H, Villadsen GE, et al. Chemoembolization of intermediate stage hepatocellular carcinomas: results from a Nordic tertiary liver cancer center. Indian J Gastroenterol. 2014;33(4):322\u2013329. doi:10.1007/s12664-013-0428-9", "ArticleIdList": ["10.1007/s12664-013-0428-9", "24307495"]}, {"Citation": "Blackburn H, West S. Management of postembolization syndrome following hepatic transarterial chemoembolization for primary or metastatic liver cancer. Cancer Nurs. 2016;39(5):E1\u2013E18. doi:10.1097/NCC.0000000000000302", "ArticleIdList": ["10.1097/NCC.0000000000000302", "26484962"]}, {"Citation": "Iolascon G, Moretti A. Pharmacotherapeutic options for complex regional pain syndrome. Expert Opin Pharmacother. 2019;20(11):1377\u20131386. doi:10.1080/14656566.2019.1612367", "ArticleIdList": ["10.1080/14656566.2019.1612367", "31063415"]}, {"Citation": "Zhou D, Wang L, Cui Q, et al. Repositioning lidocaine as an anticancer drug: the role beyond anesthesia. Front Cell Dev Biol. 2020;8:565. doi:10.3389/fcell.2020.00565", "ArticleIdList": ["10.3389/fcell.2020.00565", "PMC7379838", "32766241"]}, {"Citation": "Lee SH, Hahn ST, Park SH. Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration. Cardiovasc Intervent Radiol. 2001;24(6):368\u2013371. doi:10.1007/s00270-001-0073-z", "ArticleIdList": ["10.1007/s00270-001-0073-z", "11907741"]}, {"Citation": "Yang ZW, Zou RH, Zheng Y, et al. Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolization. Eur Radiol. 2019;29(11):5752\u20135762. doi:10.1007/s00330-019-06157-0", "ArticleIdList": ["10.1007/s00330-019-06157-0", "30993438"]}, {"Citation": "Gaba RC, Lewandowski RJ, Hickey R, et al. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2016;27(4):457\u2013473. doi:10.1016/j.jvir.2015.12.752", "ArticleIdList": ["10.1016/j.jvir.2015.12.752", "26851158"]}, {"Citation": "Wang ZX, Liu SL, Sun CH, et al. Psychological intervention reduces postembolization pain during hepatic arterial chemoembolization therapy: a complementary approach to drug analgesia. World J Gastroenterol. 2008;14(6):931\u2013935. doi:10.3748/wjg.14.931", "ArticleIdList": ["10.3748/wjg.14.931", "PMC2687062", "18240352"]}, {"Citation": "Lima M, Dutra S, Gomes FV, et al. Risk factors for the development of postembolization syndrome after transarterial chemoembolization for hepatocellular carcinoma treatment. Acta Med Port. 2018;31(1):22\u201329. doi:10.20344/amp.8976", "ArticleIdList": ["10.20344/amp.8976", "29573765"]}, {"Citation": "Benzakoun J, Ronot M, Lagadec M, et al. Risks factors for severe pain after selective liver transarterial chemoembolization. Liver Int. 2017;37(4):583\u2013591. doi:10.1111/liv.13235", "ArticleIdList": ["10.1111/liv.13235", "27529160"]}, {"Citation": "Khalaf MH, Sundaram V, Mohammed MAA, et al. A predictive model for postembolization syndrome after transarterial hepatic chemoembolization of hepatocellular carcinoma. Radiology. 2019;290(1):254\u2013261. doi:10.1148/radiol.2018180257", "ArticleIdList": ["10.1148/radiol.2018180257", "30299233"]}, {"Citation": "Zhou B, Wang JH, Yan ZP, et al. Liver cancer: effects, safety, and cost-effectiveness of controlled-release oxycodone for pain control after TACE. Radiology. 2012;262(3):1014\u20131021. doi:10.1148/radiol.11110552", "ArticleIdList": ["10.1148/radiol.11110552", "22357901"]}, {"Citation": "Lv N, Kong Y, Mu L, et al. Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial. Eur Radiol. 2016;26(10):3492\u20133499. doi:10.1007/s00330-016-4207-8", "ArticleIdList": ["10.1007/s00330-016-4207-8", "26801163"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "8", "Day": "5"}, {"Year": "2021", "Month": "9", "Day": "23"}, {"Year": "2021", "Month": "10", "Day": "22", "Hour": "6", "Minute": "53"}, {"Year": "2021", "Month": "10", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "10", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["34676180", "PMC8502067", "10.2147/JHC.S331779", "331779"]}}], "PubmedBookArticle": []}